$3,500.00
GBI Research’s report: “Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for .....
Published: May-2013
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research: “ADHD Therapeutics Market to 2018 - New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of .....
Published: Apr-2013
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Neurodegenerative Diseases Market to 2018 - New Product Entries in Both Niche and Broader Parkinson’s Diseas.....
Published: Mar-2013
|
$3,500.00
Leading business intelligence provider GBI Research has released its latest research report, entitled “Opioids Market Overview – Increasing Concentration of Abuse-Resistant Branded Generics Alter Comp.....
Published: Jan-2013
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) .....
Published: Oct-2012
|
$3,500.00
Leading business intelligence provider GBI Research has released its latest research report, entitled “Substance Abuse Therapeutics Market to 2018 - Effective Drug Therapies in the Treatment of Alcoho.....
Published: Aug-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Prescribing Trends in Opioids- Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthroug.....
Published: May-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Orphan Diseases Therapeutics in CNS to 2017-Novel Agents such as AMR101 and ACR16 to Provide Treatment Optio.....
Published: Apr-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of .....
Published: Jan-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Pain Management Therapeutics Market to 2017 – Price Competition to Intensify Following Patent Expiries of L.....
Published: Nov-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Neurodegenerative Disease Market to 2017 – Patent Expiries of High Selling Drugs Such as Aricept, Namenda, A.....
Published: Oct-2011
|
$3,500.00
GBI Research's report “Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010”, prov.....
Published: Oct-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthr.....
Published: Jun-2011
|
$3,500.00
GBI Research has released its research “Sleep Disorders Market to 2017- Generics Substitution Coupled with a Weak Pipeline Will Negatively Impact the Market”, which provides insights into sleep disord.....
Published: Apr-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Anticonvulsants Market to 2016 –Cost Advantage and Dosage Convenience Provided by Generic Anticonvulsants W.....
Published: Jan-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmark.....
Published: Dec-2009
|